Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Pfizer (Germany)
h-index: 70
Total citations: 26,157
Total papers: 901
Homepage:
https://www.pfizer.de/
Recent papers from Pfizer (Germany)
Post-Pandemic Burden of Illness Among Patients in Germany Aged ≥60 Years with Acute or Persistent COVID-19
COVID · 2026
Economic Burden of Post-COVID Syndrome in Germany Between 2021 and 2025: A Statutory Health Insurance Claims Data Analysis
Journal of health economics and outcomes research · 2026
Automation of literature screening for meta-analyses in the field of psychology: an evaluation of two text-mining approaches
Systematic Reviews · 2026
Cost-effectiveness of RSVpreF for the prevention of respiratory syncytial virus illness among high-risk adults in Germany
Expert Review of Vaccines · 2026
Broadening the Assessment of Antimicrobial Value: Insights from Two Evaluations of Aztreonam–Avibactam in Spain
Infectious Diseases and Therapy · 2026
Leveraging Large Language Models to Address Common Vaccination Myths and Misconceptions
Vaccines · 2026
Long-term sequelae after tick-borne encephalitis in Germany: a nationwide claims-based matched cohort study
Ticks and Tick-borne Diseases · 2026
The Clinical and Symptomatic Burden Among Older Adults with Respiratory Syncytial Virus: A Real-World Survey in Five European Countries
Infectious Diseases and Therapy · 2026
Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: a systematic literature review of real-world evidence
The Breast · 2026
Safety and Immunogenicity of 20-valent Pneumococcal Conjugate Vaccine According to Number and Timing of Primary Series Doses
The Pediatric Infectious Disease Journal · 2026
TALAPRO-3: Talazoparib (TALA) + enzalutamide (ENZA) compared with placebo (PBO) + ENZA for the treatment of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) harboring homologous recombination repair (HRR) gene alterations.
Journal of Clinical Oncology · 2026
PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer
New England Journal of Medicine · 2026
Effectiveness outcomes by treatment-free interval among patients receiving palbociclib plus endocrine therapy in HR+/HER2− advanced breast cancer in the real-world setting: Results from the PERFORM study.
Journal of Clinical Oncology · 2026
462P Real-world effectiveness of 2nd-line treatments following 1L palbociclib + endocrine therapy: Preliminary results from the non-interventional study PERFORM
ESMO Open · 2026
Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of Vitiligo
Dermatology and Therapy · 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe.
2026
Cost-Effectiveness of Alternative Immunization Strategies to Protect Infants Against Respiratory Syncytial Virus in Germany: A Decision Modeling Study
Infectious Diseases and Therapy · 2026
Patients with Atopic Dermatitis and Insufficient Response to Conventional Systemic Therapy in Germany: A Health Claims Data Analysis
Dermatology and Therapy · 2026
Fast and scalable retrosynthetic planning with a transformer neural network and speculative beam search
Digital Discovery · 2026
Resource use and economic burden of respiratory syncytial virus among older adults in real-world clinical practice across five European countries
Frontiers in Public Health · 2026